Glaxo Lacks Diversified Drug Portfolio: Rundquist

July 24 (Bloomberg) -- Odile Rundquist, senior analyst at Helvea, previews quarterly results from Glaxo Smithkline, looks at the impact of the drugmaker's recent troubles in China and compares the U.S. and European pharma sectors. She speaks on Bloomberg Television's "On The Move."
Does Apple TV Need a Revamp?
12:35 - Homebrew VC Partner Hunter Walk, Technalysis Founder Bob O’Donnell and IDC Chief Research Officer Crawford Del Prete discuss Apple to unveil a new TV box this fall and the future of Apple’s streaming service. They speak with Bloomberg’s Emily Chang on “Bloomberg West.” (Source: Bloomberg)
  • Why Would Microsoft Invest in Uber?
  • Why U.S. Wage Growth Has Screeched to a Halt
  • The China Slowdown Felt Around the World